Gene Network Sciences employs massively parallel supercomputers to probe vast amounts of raw human biological data, discovering new insights into the biological causes of human disease -- and new opportunities for diagnosis and treatment. Learn more
6/23/09 — Forbes Magazine's AI Report features an article entitled "Why Computers Can't—Yet—Beat the Market" by FINA CEO Josh Holden. > Read More
5/05/09 — Gene Network Sciences is awarded a patent covering the REFSTM platform. > Read More
4/28/09 — Gene Network Sciences names former Wyeth President of R&D Robert Ruffolo to its Scientific Advisory Board. > Read More
6/3/09 — Gene Network Sciences announces a cancer collaboration with the University of Connecticut Health Center's Neag Comprehensive Cancer Center. > Read More
5/27/09 — Gene Network Sciences announces a broad cancer collaboration with The University of California at San Francisco, together with initial results. > Read More